ランキング
価格
はじめての方へ
ログイン
無料体験
米国企業
BIOLASE, INC
BIOLASE, INC
BIOL
時価総額
$12.7万
PER
マイリストに追加
マイリストに追加
サマリーテーブルに戻る
十億
百万
千
USD
年次
四半期
Download CSV
損益計算書
バランスシート
キャッシュフロー
2011年
12月31日
2012年
12月31日
2013年
12月31日
2014年
12月31日
2015年
12月31日
2016年
12月31日
2017年
12月31日
2018年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
Net loss
-
-
-
-
-
-
-
-22
-18
-17
-16
-29
Depreciation and amortization
1
1
1
1
1
1
1
1
1
0
0
0
Provision for bad debts
-
0
0
1
0
-0
0
0
2
1
-0
0
Provision for sales returns
-
-
-
-
-
-
-
-
-
0
-
-
Inventory Write-down
-
0
1
1
1
0
1
0
0
-1
-0
1
Inventory disposals and recoveries, net
-
-
-
-
-
-
-
-
-
-1
0
-1
Amortization of debt issuance costs
0
0
0
0
-
-
-
0
0
0
0
1
Patent litigation mark-to-market
-
-
-
-
-
-
-
-
-
-
0
-
Change in fair value of warrants
-
-
-
-
-
-
-
-
-
-6
-
-
Issuance Of Restricted Shares
-
-
-
-
-
-
-
-
-
-
0
0
Issuance costs for common stock warrants
-
-
-
-
-
-
-
-
-
2
-
-
Stock-based compensation
2
2
2
1
-
3
2
3
3
3
2
2
Gain on debt forgiveness
-0
-
-
-
-
-
-
-
-
-
3
-
Accounts receivable
6
3
-0
-1
0
1
0
1
-1
-4
1
2
Inventory
5
0
1
2
1
2
-0
0
-1
1
1
6
Prepaid expenses and other current assets
1
-0
-0
0
0
-0
0
0
-0
-1
-0
1
Accounts payable and accrued liabilities
4
-0
-1
0
-1
3
-5
2
-3
-2
2
4
Deferred revenue
-
-
-
-
-
-
-
-0
0
-0
0
-0
Net cash and cash equivalents used in operating activities
-13
-2
-9
-
-
-
-
-14
-13
-13
-17
-27
Purchases of property, plant, and equipment
0
1
1
0
2
1
1
1
0
0
1
4
Net cash and cash equivalents used in investing activities
-0
-1
-1
-
-
-
-
-1
-0
-0
-1
-4
Proceeds from the sale of common stock
17
-
5
51
-
10
-
-
9
-
-
6
Proceeds From Sale Of Preferred Stock
-
-
-
-
-
-
-
-
-
3
-
-
Proceeds From Sale Of Common Stock Warrants
-
-
-
-
-
-
-
-
-
15
-
-
Payments of equity offering costs
-
-
-
-
-
-
-
0
-
1
1
-
Payment of July 2020 Warrant issuance costs
-
-
-
-
-
-
-
-
-
2
-
-
Borrowings on other long-term loans
-
-
-
-
-
-
-
-
-
3
-
-
Principal payment on term loan
-
-
-
-
-
-
-
-
-
1
-
1
Borrowings on credit facility
-
17
35
17
-
-
-
4
-
3
-
-
Payments of credit facility
-
15
32
22
-
-
-
4
-
3
-
-
Payments of debt issuance costs
-
0
0
0
-
-
-
1
0
0
0
-
Proceeds from Warrant Exercises
0
0
-
-
-
-
-
-
-
0
17
0
Proceeds from exercise of stock options
-
-
-
-
-
-
-
0
0
-
0
-
Net cash and cash equivalents provided by financing activities
15
2
9
-
-
-
-
11
11
24
30
5
Effect of exchange rate changes
-
-
-
-
-
-
-
-
-
-
-
-0
Increase (decrease) in cash and cash equivalents
-
-
-
-
-
-
-
-4
-2
12
12
-26
Cash paid for interest
-
-
-
-
-
-
-
0
2
2
2
2
Cash received for interest
-
-
-
-
-
-
-
-
-
0
0
0
Income Taxes Paid, Net
0
0
0
0
0
0
0
0
0
0
0
0
Cash paid for operating leases
-
-
-
-
-
-
-
-
1
0
0
0
Non-cash settlement of liability
-
-
-
-
-
-
-
-
-
0
1
-
Non Cash Right Of Use Assets Obtained In Exchange For Lease Obligation
-
-
-
-
-
-
-
-
-
2
0
1
Equity financing costs in accounts payable
-
-
-
-
-
-
-
-
0
0
-
-
Dividends, Preferred Stock, Stock
-
-
-
-
-
-
-
-
-
17
1
0
Forgiveness of debt
-
-
-
-
-
-
-
-
-
0
-
-
Receivable From WarrantsExercised And Included In Prepaid And Other Current Assets
-
-
-
-
-
-
-
-
-
1
-1
-
Debt Conversion, Converted Instrument, Amount
-
-
-
-
-
-
-
1
0
0
-
-